Search

everythinglearnresearchcommunity

for

Search:↓

Most patients with Lichen planopilaris improved with acitretin, but treatments often didn't work well; preventing infection in skin surgery is important, and bupivacaine might be a better anesthetic.

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.

Hair follicles are normally protected from the immune system, but when this protection fails, it can cause hair loss in alopecia areata.

Minoxidil is the only FDA-approved topical drug for treating male or female pattern hair loss, and other medications like finasteride and dutasteride can also increase hair growth.

Tofacitinib helped regrow hair in people with severe alopecia, but side effects occurred and benefits stopped after treatment ended.

Both vitiligo and alopecia areata involve an immune response triggered by stress and specific genes, with treatments targeting this pathway showing potential.

Cancer can hijack the body's cell repair system to promote tumor growth, and targeting this process may improve cancer treatments.

New insights into the causes and treatments for the autoimmune hair loss condition Alopecia areata have been made.

The conclusion is that acne, alopecia, and hyperhidrosis are common skin issues with various treatments available, and accurate diagnosis is key for effective management.

MDSC-Exo can treat autoimmune alopecia areata and promote hair regrowth in mice.

Bimatoprost is promising for treating some types of hair loss but needs more testing for androgenetic alopecia.

Stress can cause early aging in certain skin cells, leading to problems with hair growth.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Topical ruxolitinib failed to regrow hair in a 66-year-old with alopecia areata.

Ruxolitinib effectively and safely regrows hair in alopecia patients.

Targeting Vδ1+T-cells may help treat alopecia areata.

The current understanding of frontal fibrosing alopecia involves immune, genetic, hormonal factors, and possibly environmental triggers, but more research is needed for effective treatments.

Thiopurines help treat IBD but require genetic testing to avoid side effects.

Topical DPCP is somewhat effective for hair loss in alopecia areata, but more research is needed.

A gene variant increases the risk of a type of hair loss by affecting hair protein production.

Tofacitinib is effective and safe for long-term treatment of severe alopecia areata, with many patients achieving complete hair regrowth.

Alopecia Areata is an autoimmune hair loss condition that needs more research for better treatments.

Leptin, a hormone from fat cells, affects immune responses and can influence skin diseases and hair growth.

Eleven traditional Polynesian plants show potential for natural anti-aging, hair growth, and skin brightening products.

Hair follicle stem cells reduced hair loss and inflammation in mice with a condition similar to human alopecia.

Non-coding RNAs are important for hair growth and could lead to new hair loss treatments, but more research is needed.

Tofacitinib helps regrow hair in severe alopecia patients, but more research is needed.

Several new treatments for different types of hair loss show promise in improving patient quality of life.

Exosomes from fat-derived stem cells can potentially improve hair growth and could be a new treatment for immune-related hair loss.

Some skin medications can have harmful interactions with the COVID-19 drug nirmatrelvir-ritonavir, but not with molnupiravir.